Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation

Molecular and Cellular Biology

Volumn 17, Issue 3, 1997, Pages 1682-1691

  Lebrun, J J ^a   Vale, W W ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; INHIBIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ERYTHROPOIESIS; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL;

EID: 0031018483     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.3.1682     Document Type: Article

References (41)

1. Attisano, L., J. L. Wrana, S. Cheifetz, and J. Massagué. 1992. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68:97-108.
2. Attisano, L., J. Carcamo, F. Ventura, F. M. B. Weis, J. Massagué, and J. L. Wrana. 1993. Identification of human activin and TGFβ type I receptors that form heterodimeric kinase complexes with type II receptors. Cell 75:671-680.
3. Attisano, L., J. L. Wrana, E. Montalvo, and J. Massagué. 1996. Activation of signaling by the activin receptor complex. Mol. Cell. Biol. 16:1066-1073.
4. Bilezikjian, L. M., and W. W. Vale. 1992. Local extragonadal roles of activins. Trends Endocrinol. Metab. 3:218-223.
5. Broxmeyer, H. E., L. Lu, S. Cooper, R. H. Schwall, A. J. Mason, and K. Nikolics. 1988. Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. Proc. Natl. Acad. Sci. USA 85:9052.
6. Carcamo, J., F. M. B. Weis, F. Ventura, R. Weiser, J. L. Wrana, L. Attisano, and J. Massagué. 1994. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell. Biol. 14:3810-3821.
7. Chen, F., and R. A. Weinberg. 1995. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc. Natl. Acad. Sci. USA 92:1565-1569.
8. Chen, R. H., H. L. Moses, E. M. Maruoka, R. Derynck, and M. kawabata. 1995. Phosphorylation-dependent interaction of the cytoplasmic domains of the type I and type II transforming growth factor-beta receptors. J. Biol. Chem. 270:12235-12241.
9. Cosman, D. 1993. The hematopoietin receptor super family. Cytokine 5:95-106.
10. DePaolo, L. V., T. A. Bicsak, G. F. Erickson, S. Shimasaki, and N. Ling. 1991. Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc. Soc. Exp. Biol. Med. 198:500-512.
11. Ebner, R., R. H. Chen, S. Lawler, T. Zioncheck, and R. Derynck. 1993. Determination of type I specificity by the type II receptors for TGF-beta or activin. Science 262:900-902.
12. Gonzalez-Manchon, C., and W. W. Vale. 1989. Activin A, inhibin and transforming growth factor beta modulate growth of two gonadal cell lines. Endocrinology 125:1666-1672.
13. 3H thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol. Cell. Endocrinol. 61:133-138.
14. kojima, I., and E. Ogata. 1989. Dual effect of activin A on cell growth in BALB/C 3T3 cells. Biochem. Biophys. Res. Commun. 159:1107-1113.
15. Luo, K., and H. F. Lodish. 1996. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction. EMBO J. 15:4485-4496.
16. Mather, J. P., T. K. Woodruff, and L. A. Krummen. 1992. Paracrine regulation of reproductive function by inhibin and activin. Proc. Soc. Exp. Biol. Med. 201:1-15.
17. Mathews, L. S., and W. W. Vale. 1991. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65:973-982.
18. Mathews, L. S., W. W. Vale, and C. R. Kintner. 1992. Cloning of a second type of activin receptor and functional characterization in Xenopus embryos. Science 255:1702-1705.
19. Mathews, L. S., and W. W. Vale. 1993. Characterization of type II activin receptors: binding, processing and phosphorylation. J. Biol. Chem. 268:19013-19018.
20. Matzuk, M. M., M. J. Finegold, M. J. Su, A. J. W. Hsueh, and A. Bradley. 1992. Alpha-inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319.
21. Mizuguchi, T., M. Kosaka, and S. Saito. 1993. Activin A suppresses proliferation of interleukin-3-responsive granulocyte-macrophage colony-forming progenitors and stimulates proliferation and differentiation of interleukin-3-responsive erythroid burst-forming progenitors in the peripheral blood. Blood 81:2891-2897.
22. Mosmann, T. 1983. J. Immunol. Methods 65:55.
23. Roberts, V. J., and S. L. Barth. 1994. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 134:914-923.
24. Schwall, R., C. H. Schmeltzer, E. Matsuyama, and A. J. Mason. 1989. Multiple actions of recombinant activin A in vivo. Endocrinology 125:1420.
25. Sehy, D. W., L. E. Shao, A. L. Yu, W. M. Tsai, and J. Yu. 1992. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase. J. Cell. Biochem. 50:255-265.
26. Shao, L., N. L. Frigon, A. L. Young, A. L. Yu, L. S. Mathews, J. Vaughan, W. W. Vale, and J. Yu. 1992. Effect of activin A on globin gene expression in purified human erythroid progenitors. Blood 79:773-781.
27. Shiozaki, M., R. Sakai, M. Tabuchi, Y. Eto, M. Kosaka, and H. Shibai. 1989. In vivo treatment with erythroid differentiation factor (EDF/activin A) increases erythroid precursors (CFU-E and BFU-E) in mice. Biochem. Biophys. Res. Commun. 165:1155.
28. Sporn, M. B., and A. B. Roberts. 1990. Peptide growth factors and their receptors, vol. II, p. 211-248. Springer, Berlin.
29. Ten Dijke, P., H. Ichijo, P. Franzen, P. Schulz, J. Saras, H. Toyoshima, C. H. Heldin, and K. Miyazono. 1993. Activin receptor like kinases: a novel subclass of cell surface receptors with predicted serine/threonine kinase activity. Oncogene 8:2879-2887.
30. Ten Dijke, P., H. Yamashita, H. Ichijo, P. Franzen, M. Laiho, K. Miyazono, and C. H. Heldin. 1994. Characterization of type I receptors for transforming growth factor and activin. Science 264:101-104.
31. Tsuchida, K., L. S. Mathews, and W. W. Vale. 1993. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc. Natl. Acad. Sci. USA 90:11242-11246.
32. Tsuchida, K., J. M. Vaughan, E. Wiater, D. Gaddy-Kurten, and W. W. Vale. 1996. Inactivition of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology 136:5493-5503.
33. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
34. Ventura, F., J. Doody, F. Liu, J. L. Wrana, and J. Massagué. 1994. Reconstitution and transphosphorylation of TGF-beta receptor complexes. EMBO J. 13:5581-5589.
35. Willis, S. A., C. M. Zimmerman, L. Li, and L. S. Mathews. 1996. Formation and activation by phosphorylation of activin receptor complexes. Mol. Endocrinol. 10:367-379.
36. Weis-Garcia, F., and J. Massagué. 1996. Complementation between kinase-defective and activation-defective TGFβ receptors reveals a novel form of receptor cooperativity essential for signaling. EMBO J. 15:276-289.
37. Wrana, J. L., L. Attisano, R. Wieser, F. Ventura, and J. Massagué. 1994. Mechanism of activation of the TGF-beta receptor. Nature 370:341-347.
38. Xu, J., K. McKeehan, K. Matsuzaki, and W. L. McKeehan. 1995. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J. Biol. Chem. 270:6308-6313.
39. Yamashita, H., P. ten Dijke, P. Franzen, K. Miyazono, and C. H. Heldin. 1994. Formation of heterooligomeric complexes of type I and typy II receptors for TGFβ. J. Biol. Chem. 269:20172-20178.
40. Yasuda, H., T. Mine, H. Shibata, Y. Eto, Y. Hasegawa, T. Takeuchi, S. Asano, and I. Kojima. 1993. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92:1491-1496.
41. Yu, J., L. Shao, V. Lemas, A. L. Yu, J. Vaughan, J. Rivier, and W. W. Vale. 1987. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature 330:765-767.